177 related articles for article (PubMed ID: 24260338)
1. Inhibiting cycloxygenase and ornithine decarboxylase by diclofenac and alpha-difluoromethylornithine blocks cutaneous SCCs by targeting Akt-ERK axis.
Arumugam A; Weng Z; Talwelkar SS; Chaudhary SC; Kopelovich L; Elmets CA; Afaq F; Athar M
PLoS One; 2013; 8(11):e80076. PubMed ID: 24260338
[TBL] [Abstract][Full Text] [Related]
2. Herbacetin suppresses cutaneous squamous cell carcinoma and melanoma cell growth by targeting AKT and ODC.
Kim DJ; Lee MH; Liu K; Lim DY; Roh E; Chen H; Kim SH; Shim JH; Kim MO; Li W; Ma F; Fredimoses M; Bode AM; Dong Z
Carcinogenesis; 2017 Oct; 38(11):1136-1146. PubMed ID: 29029040
[TBL] [Abstract][Full Text] [Related]
3. Ornithine decarboxylase inhibition by alpha-difluoromethylornithine activates opposing signaling pathways via phosphorylation of both Akt/protein kinase B and p27Kip1 in neuroblastoma.
Koomoa DL; Yco LP; Borsics T; Wallick CJ; Bachmann AS
Cancer Res; 2008 Dec; 68(23):9825-31. PubMed ID: 19047162
[TBL] [Abstract][Full Text] [Related]
4. Ornithine decarboxylase inhibition downregulates multiple pathways involved in the formation of precancerous lesions of esophageal squamous cell cancer.
Xie Y; Dong CD; Wu Q; Jiang Y; Yao K; Zhang J; Zhao S; Ren Y; Yuan Q; Chen X; Liu Z; Zhao J; Liu K
Mol Carcinog; 2020 Feb; 59(2):215-226. PubMed ID: 31793679
[TBL] [Abstract][Full Text] [Related]
5. Combined inhibition of p38 and Akt signaling pathways abrogates cyclosporine A-mediated pathogenesis of aggressive skin SCCs.
Arumugam A; Walsh SB; Xu J; Afaq F; Elmets CA; Athar M
Biochem Biophys Res Commun; 2012 Aug; 425(2):177-81. PubMed ID: 22820192
[TBL] [Abstract][Full Text] [Related]
6. Induction of ornithine decarboxylase activity is a necessary step for mitogen-activated protein kinase kinase-induced skin tumorigenesis.
Feith DJ; Bol DK; Carboni JM; Lynch MJ; Sass-Kuhn S; Shoop PL; Shantz LM
Cancer Res; 2005 Jan; 65(2):572-8. PubMed ID: 15695401
[TBL] [Abstract][Full Text] [Related]
7. Eflornithine (DFMO) prevents progression of pancreatic cancer by modulating ornithine decarboxylase signaling.
Mohammed A; Janakiram NB; Madka V; Ritchie RL; Brewer M; Biddick L; Patlolla JM; Sadeghi M; Lightfoot S; Steele VE; Rao CV
Cancer Prev Res (Phila); 2014 Dec; 7(12):1198-209. PubMed ID: 25248858
[TBL] [Abstract][Full Text] [Related]
8. Difluoromethylornithine Induces Apoptosis through Regulation of AP-1 Signaling via JNK Phosphorylation in Epithelial Ovarian Cancer.
Hwang WY; Park WH; Suh DH; Kim K; Kim YB; No JH
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638596
[TBL] [Abstract][Full Text] [Related]
9. Influence of gastrin, gastrin receptor blockers, epidermal growth factor, and difluoromethylornithine on the growth and the activity of ornithine decarboxylase of colonic carcinoma cells.
Eggstein S; Imdahl A; Kohler M; Waibel M; Farthmann EH
J Cancer Res Clin Oncol; 1991; 117(1):37-42. PubMed ID: 1997467
[TBL] [Abstract][Full Text] [Related]
10. Ochratoxin A-induced cell proliferation and tumor promotion in mouse skin by activating the expression of cyclin-D1 and cyclooxygenase-2 through nuclear factor-kappa B and activator protein-1.
Kumar R; Alam S; Chaudhari BP; Dwivedi PD; Jain SK; Ansari KM; Das M
Carcinogenesis; 2013 Mar; 34(3):647-57. PubMed ID: 23172667
[TBL] [Abstract][Full Text] [Related]
11. Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway.
Chaudhary SC; Kurundkar D; Elmets CA; Kopelovich L; Athar M
Photochem Photobiol; 2012; 88(5):1149-56. PubMed ID: 22540890
[TBL] [Abstract][Full Text] [Related]
12. Evidence that AMP-activated protein kinase can negatively modulate ornithine decarboxylase activity in cardiac myoblasts.
Passariello CL; Gottardi D; Cetrullo S; Zini M; Campana G; Tantini B; Pignatti C; Flamigni F; Guarnieri C; Caldarera CM; Stefanelli C
Biochim Biophys Acta; 2012 Apr; 1823(4):800-7. PubMed ID: 22230191
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in ODC/Ras transgenic mice.
Lan L; Trempus C; Gilmour SK
Cancer Res; 2000 Oct; 60(20):5696-703. PubMed ID: 11059762
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human ornithine decarboxylase activity by enantiomers of difluoromethylornithine.
Qu N; Ignatenko NA; Yamauchi P; Stringer DE; Levenson C; Shannon P; Perrin S; Gerner EW
Biochem J; 2003 Oct; 375(Pt 2):465-70. PubMed ID: 12859253
[TBL] [Abstract][Full Text] [Related]
15. AMXT-1501, a novel polyamine transport inhibitor, synergizes with DFMO in inhibiting neuroblastoma cell proliferation by targeting both ornithine decarboxylase and polyamine transport.
Samal K; Zhao P; Kendzicky A; Yco LP; McClung H; Gerner E; Burns M; Bachmann AS; Sholler G
Int J Cancer; 2013 Sep; 133(6):1323-33. PubMed ID: 23457004
[TBL] [Abstract][Full Text] [Related]
16. Ornithine decarboxylase is a target for chemoprevention of basal and squamous cell carcinomas in Ptch1+/- mice.
Tang X; Kim AL; Feith DJ; Pegg AE; Russo J; Zhang H; Aszterbaum M; Kopelovich L; Epstein EH; Bickers DR; Athar M
J Clin Invest; 2004 Mar; 113(6):867-75. PubMed ID: 15067319
[TBL] [Abstract][Full Text] [Related]
17. Effect of alpha-difluoromethyl-ornithine on the expression and function of the epidermal growth factor receptor in human breast epithelial cells in culture.
Manni A; Trout D; Verderame MF; Washington S; Mauger D; Demers L
Breast Cancer Res Treat; 2001 Jul; 68(2):139-46. PubMed ID: 11688517
[TBL] [Abstract][Full Text] [Related]
18. Co-targeting PI3K/Akt and MAPK/ERK pathways leads to an enhanced antitumor effect on human hypopharyngeal squamous cell carcinoma.
Peng X; Liu Y; Zhu S; Peng X; Li H; Jiao W; Lin P; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2921-2936. PubMed ID: 31620898
[TBL] [Abstract][Full Text] [Related]
19. DFMO/eflornithine inhibits migration and invasion downstream of MYCN and involves p27Kip1 activity in neuroblastoma.
Koomoa DL; Geerts D; Lange I; Koster J; Pegg AE; Feith DJ; Bachmann AS
Int J Oncol; 2013 Apr; 42(4):1219-28. PubMed ID: 23440295
[TBL] [Abstract][Full Text] [Related]
20. EGFR plays a pivotal role in the regulation of polyamine-dependent apoptosis in intestinal epithelial cells.
Ray RM; Bhattacharya S; Johnson LR
Cell Signal; 2007 Dec; 19(12):2519-27. PubMed ID: 17825525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
